Citation Information :
Kumawat SK, Ish P, Kumar R, Gupta N, Madan M. Role of Adaptive Servo-ventilation in Sleep-disordered Breathing: An Updated Evidence. Indian Sleep Med 2024; 19 (4):78-79.
Kapur VK, Auckley DH, Chowdhuri S, et al. Clinical practice guideline for diagnostic testing for adult obstructive sleep apnea: An American Academy of Sleep Medicine clinical practice guideline. J Clin Sleep Med 2017;13(3):479–504. DOI: 10.5664/jcsm.6506.
Oldenburg O, Lamp B, Faber L, et al. Sleep-disordered breathing in patients with symptomatic heart failure: A contemporary study of prevalence in and characteristics of 700 patients. Eur J Heart Fail 2007;9(3):251–257. DOI: 10.1016/j.ejheart.2006.08.003.
Lévy P, Pépin J-L, Tamisier R, et al. Prevalence and impact of central sleep apnea in heart failure. Sleep Med Clin 2007;2(4):615–621. DOI: 10.1016/j.jsmc.2007.08.001.
Gupta N, Agrawal S, Goel AD, et al. Profile of sleep disordered breathing in heart failure with preserved ejection fraction. Monaldi Arch Chest Dis 2020;90(4). DOI: 10.4081/monaldi.2020.1329.
Agrawal S, Gupta N, Ish P, et al. Sleep-disordered breathing in heart failure: A complex bidirectional pathophysiology. Indian Sleep Med 2019:14(4);70–75. PMID: 18350961.
Selim B, Ramar K. Advanced positive airway pressure modes: Adaptive servo ventilation and volume assured pressure support. Expert Rev Med Devices 2016;13(9):839–851. DOI: 10.1080/17434440.2016.1218759.
Momomura S. Treatment of cheyne-Stokes respiration-central sleep apnea in patients with heart failure. J Cardiol 2012;59(2):110–116. DOI: 10.1016/j.jjcc.2011.12.008.
Bradley TD, Logan AG, Kimoff RJ, et al. Continuous positive airway pressure for central sleep apnea and heart failure. N Engl J Med 2005;353(19):2025–2033. DOI: 10.1056/NEJMoa051001.
Cowie MR, Woehrle H, Wegscheider K, et al. Adaptive servo-ventilation for central sleep apnea in systolic heart failure. N Engl J Med 2015;373(12):1095–1105. DOI: 10.1056/NEJMoa1506459.
Bradley TD, Logan AG, Filho GL, et al. Adaptive servo-ventilation for sleep-disordered breathing in patients with heart failure with reduced ejection fraction (ADVENT-HF): A multicentre, multinational, parallel-group, open-label, phase 3 randomised controlled trial. Lancet Respir Med 2023;12(2):153–166. DOI: 10.1016/S2213-2600(23)00374-0.